Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: Biomaterials. 2014 Apr 8;35(21):5491–5504. doi: 10.1016/j.biomaterials.2014.03.039

Fig. 8.

Fig. 8

Protection against A20 B-Lymphoma. A) Time line for prophylactic immunization and tumor inoculation, B) Median survival table, and C) Kaplan-Meier survival curve for immunized Balb/C mice with various formulations after lethal challenge of A20 B-lymphoma cells (2 ×105 cells/mice IP).